In the present study, we evaluated the effect of weight loss and concomitant improvements in whole-body insulin sensitivity, induced by diet therapy alone and by bariatric surgical procedures that either maintain (LAGB) or disrupt the continuity of the upper gastrointestinal tract (RYGB) on β cell function in people with obesity with and without T2D. This evidence concerns the gene INS and obesity disorder.